Xiamen University
Xiamen, China · 21 authors
Xiamen University (Xiamen, China): 21 authors and 8 papers in the de novo peptide sequencing catalog.
Departments
- The First Affiliated Hospital of Xiamen University, School of Medicine
Papers (8)
- XA-Novo: an accurate and high-throughput mass spectrometry-based de novo sequencing technology for monoclonal antibodies and antibody mixtures (2026, Nature Communications)
- AbNovoBench: a resource and benchmarking platform for monoclonal antibody de novo sequencing (2026, bioRxiv)
- XA-Novo: an accurate and high-throughput mass spectrometry-based de novo sequencing technology for monoclonal antibodies and antibody mixtures (2025, Research Square)
- Simplified and Rapid Workflow Enhances Throughput of De Novo Sequencing of COVID-19 Neutralizing Antibodies (2024, bioRxiv)
- Comprehensive assembly of monoclonal and mixed antibody sequences (2024, bioRxiv)
- Stable Isotope N-Phosphorylation Labeling for Peptide de Novo Sequencing and Protein Quantification Based on Organic Phosphorus Chemistry (2012, Analytical Chemistry)
- Identification and Characterization of Cell Wall Proteins of a Toxic Dinoflagellate Alexandrium catenella Using 2‐D DIGE and MALDI TOF‐TOF Mass Spectrometry (2011, Evidence-Based Complementary and Alternative Medicine)
- Homology‐Driven Proteomics of Dinoflagellates with Unsequenced Genomes Using MALDI‐TOF/TOF and Automated De Novo Sequencing (2011, Evidence-Based Complementary and Alternative Medicine)
Its patents citing catalogued ones (2)
- CN115828152A A method, system and storage medium for anticancer peptide classification based on graph convolutional network (priority 2022-11-22) cites CN113921086A
- CN113362899B Deep learning-based protein mass spectrum data analysis method and system (priority 2021-04-20) cites US11694769B2, US11644470B2
Patent families filed by this organisation that cite a patent family catalogued here, as Google Patents lists the citations.